FDA Watch List: Fluoroquinolone
Fluoroquinolone antibiotics that are commonly taken to treat respiratory or urinary tract infections have been listed on the Food and Drug Administration’s most recent “Adverse Event Reporting System” list . The reason for their inclusion on the list is the FDA’s need to investigate a potential link between the antibiotics’ usage and peripheral sensorimotor neuropathy